Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine for Recurrent/Progressive Malignant Gliomas
NCT00590954Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- May 2006
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perifosine in malignant glioma, glioblastoma (GBM), sponsored by Memorial Sloan Kettering Cancer Center. Started May 2006; status: completed.
02
Drugs
perifosine
03
Conditions
malignant gliomaglioblastoma (GBM)
Beyond the preview
Go deeper on NCT00590954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00590954.